teleo/teleo-codex
8
0
Fork 0
Code Issues 22 Pull requests 85 Projects Releases Packages Wiki Activity Actions 104
teleo-codex/entities/health/neda.md
Teleo Agents eb513503b5 vida: extract claims from 2025-xx-neda-anad-glp1-eating-disorders-clinical-guidance 
- Source: inbox/queue/2025-xx-neda-anad-glp1-eating-disorders-clinical-guidance.md
- Domain: health
- Claims: 2, Entities: 2
- Enrichments: 3
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>
2026-05-04 04:22:54 +00:00

1.3 KiB
Raw Blame History

title type entity_type domain status
National Eating Disorders Association (NEDA) entity organization health active

National Eating Disorders Association (NEDA)

Leading U.S. advocacy and clinical guidance organization for eating disorder treatment and prevention.

Timeline

  • 2025-01-01 — Published joint clinical guidance with ANAD on GLP-1 receptor agonist use in eating disorder populations, recommending tri-specialist care teams and identifying contraindications including current/past anorexia nervosa, active restrictive behaviors, and severe body image issues

Overview

NEDA provides clinical guidance, advocacy, and resources for eating disorder treatment. Their recommendations carry professional authority but no regulatory force—guidance creates clinical standards without legal mandates.

Key Positions

GLP-1 Contraindications (2025):

  • Current or past anorexia nervosa or atypical anorexia nervosa
  • Active restrictive behaviors, bingeing, or purging
  • Severe body image issues or unstable recovery
  • Lack of appropriate monitoring or multidisciplinary support
  • Signs the medication is being sought solely for weight loss

NEDA notes there are no FDA warnings for eating disorder populations—all guidance is professional society recommendation only.